QuantaMatrix Inc. announced that it has received KRW 17.5 billion in funding from Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., The Korea Securities Finance Corporation, KB Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.
March 08, 2024
Share
On March 8, 2024, QuantaMatrix Inc. closed the transaction.
QuantaMatrix Inc is a Korean-based company engaged in the development and production of in vitro diagnostics (IVD) medical devices. The Company's main products include a multi-diagnostic unique test platform, micro disc, antimicrobial susceptibility testing sepsis diagnostic equipment, molecular immunity diagnosis automation platform, rapid antituberculosis susceptibility testing equipment, rapid antituberculosis susceptibility testing kits, and others. In addition, the Company sells covid kits and engages in research and development of microbial diagnostic products.
QuantaMatrix Inc. announced that it has received KRW 17.5 billion in funding from Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., The Korea Securities Finance Corporation, KB Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.
QUANTAMATRIX INC. 
